Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents

NCT02201342 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Single Ventricle Heart Disease After Fontan Surgery

Interventions

DRUG: Udenafil

Sponsor

Mezzion Pharma Co. Ltd

Collaborators

[object Object]
[object Object]